FDA to issue new warning for J&J COVID jab - report

Montag, 12. Juli 2021 19:58

The United States Food and Drug Administration is expected to unveil it will add a new warning label on the Johnson & Johnson coronavirus vaccine, in relation to the possibility of developing an autoimmune disorder, the Guillain-Barré syndrome.

According to a report published by the Washington Post on Monday, the health watchdog saw around 100 cases of the disease from 12.8 million doses issued. However, the agency is also likely to note that the benefits of getting the jab far outweigh the risks, with some indicating that the link between the two isn't definitive but rather just likely.

On the topic of other types of vaccines, at the moment the report stated that there seems to be no similar pattern in a rise in cases of the Guillain-Barré syndrome, but the topic will be covered at the upcoming meeting of the Centers for Disease Control and Prevention advisers.

Relevante Links: Johnson & Johnson
Baha Breaking the News (BBN) / OL